CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
TrAVeRse is a multicentre, open-label, randomised, Phase II study of AVR in treatment naïve MCL participants. The primary objective will be to assess...
Phase 2
Warszawa, Poland and 47 other locations
First-in-human, open-label, sequential dose escalation and expansion study of CPI-0209 in patients with advanced solid tumors and lymphomas....
Phase 1, Phase 2
Warsaw, Poland and 50 other locations
dose of BGB-11417 monotherapy for relapsed or refractory mantle cell lymphoma. Part 2 evaluates efficacy of BGB-11417 monotherapy at the rec...
Phase 1, Phase 2
Warszawa, Poland and 104 other locations
treatment of advanced classical Hodgkin lymphoma(HL)...
Phase 3
Warszawa, Poland and 215 other locations
The purpose of this study is to assess the antitumor efficacy of single-agent brentuximab vedotin 1.8 mg/kg administered intravenously (IV) every 3 w...
Phase 4
Warszawa, Poland and 39 other locations
purpose of this study is to assess the objective response rate of parsaclisib treatment in participants with relapsed or refractory follicular lymphoma...
Phase 2
Warszawa, Poland and 82 other locations
in participants diagnosed with relapsed or refractory marginal zone lymphoma (MZL) who are naive to or were previously treated with a Bruton...
Phase 2
Warsaw, Poland and 85 other locations
This Phase 3 multinational, randomized, double-blind study is designed to compare the efficacy and safety of the combination of ibrutinib and venetoc...
Phase 3
Warszawa, Poland and 119 other locations
The purpose of this study is to evaluate the efficacy of loncastuximab tesirine (ADCT-402) combined with rituximab compared to standard immunochemoth...
Phase 3
Warszawa, Poland and 140 other locations
safety of ibrutinib given in combination with bendamustine and rituximab in patients 65 years of age or older with newly diagnosed mantle cell lymphoma...
Phase 3
Warszawa, Poland and 203 other locations
Clinical trials
Research sites
Resources
Legal